The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

Area of Science:

• Molecular Biology
• Cancer Research
• Developmental Biology

Background:

• Matrix metalloproteinases (MMPs) are crucial for extracellular matrix remodeling.
• RECK (Reversion-Inducing Cysteine-Rich Proteinous Knockoff) is a known negative regulator of MMP-9, inhibiting tumor invasion and metastasis.

Purpose of the Study:

• To investigate the role of RECK in regulating other MMPs, specifically MMP-2 and MT1-MMP.
• To elucidate the in vivo function of RECK during embryonic development and its impact on tumor angiogenesis.

Main Methods:

• Analysis of RECK's regulation of MMP-2 and MT1-MMP.
• Phenotypic analysis of RECK-deficient mice, including embryonic lethality and developmental defects.
• Assessment of tumor vascular sprouting in RECK-expressing fibrosarcoma cells grown in nude mice.

Main Results:

• RECK regulates MMP-2 and MT1-MMP, enzymes implicated in cancer progression.
• Mice lacking functional RECK exhibit embryonic lethality around E10.5 with defects in collagen fibrils, basal lamina, and vascular development.
• The embryonic phenotype is partially rescued in MMP-2 null mutant mice.
• Vascular sprouting is significantly suppressed in tumors derived from RECK-expressing fibrosarcoma cells.

Conclusions:

• RECK plays a critical role in regulating MMP-2 activity in vivo.
• RECK deficiency leads to severe developmental defects, partly mediated by MMP-2.
• Downregulation of RECK is implicated in promoting tumor angiogenesis.